Drug
Chf1535 Nexthaler
Chf1535 Nexthaler: highest development phase Phase 2, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| CHF1535 NEXThaler NCT03108534 | Phase 2 | Asthma |
Latest
No recent events.
Follow Chf1535 Nexthaler on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.